EYPT Financials
Eyepoint Pharmaceuticals Inc - Financial statements & key metrics
Stock Price
$4.58
Market Cap
$1.10B
P/E Ratio
-2.0
EPS
$-3.00
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$43.27M
Gross Profit
-
Operating Income
-
Net Income
$-130.87M
EPS (Diluted)
$-2.32
Balance Sheet Highlights
Total Assets
$418.46M
Total Liabilities
$81.96M
Shareholders Equity
-
Cash & Equivalents
$99.70M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-126.23M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Operating Margin
-6420.8%
ROE
-98.2%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is EYPT revenue?
EYPT's most recent quarterly revenue was $43.27M. Annual revenue can be calculated by summing the four most recent quarters.
Is EYPT profitable?
EYPT reported a loss of $130.87M in the most recent quarter.
What is EYPT market cap?
EYPT has a market capitalization of $1.10B, making it a small-cap stock.
Does EYPT have debt?
View EYPT's balance sheet for debt information.
What is EYPT cash flow?
Cash flow data is available in the full financial statements.